This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.90% per year. These returns cover a period from January 1, 1988 through December 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Jobs Numbers Disappoint at 245K, Unemployment 6.7%
by Mark Vickery
245K new jobs were even fewer than Wednesday's private-sector ADP (ADP) number of 307K, and well below the 430-440K expected.
Vaccine Stocks Adjust, Markets Await Jobs Numbers
by Mark Vickery
There are no systemic problems with anything related to future vaccine availability overall.
5 Hot ETFs of November to Continue Gaining Investor's Love
by Sweta Killa
We have highlighted five ETFs that enjoyed huge capital inflows last month and are expected to do so should the similar trends prevail.
Initial, Continuing Claims Drop; PUA Soon to Expire
by Mark Vickery
Initial Jobless Claims for last week came in significantly lower than expected: 712K versus a 780K estimate.
ETF Asset Flow for November
by Sanghamitra Saha
U.S. stocks were super steady in November on back-to-back upbeat vaccine update.
Should John Hancock Multifactor Large Cap ETF (JHML) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JHML
Cyclical Sector Outperforming: 6 Cheap ETFs to Track
by Sweta Killa
Vaccine optimism has brought back the lure for the cyclical sector ETFs, which are attractively valued at the current levels.
Should iShares Russell Top 200 ETF (IWL) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWL
Jobless Claims Heading the Wrong Direction
by Mark Vickery
The headline figure, 778K, is the second straight week with new claims growing 30K or more, from the 711K reported two weeks ago.
Dow, S&P and Russell Set New Highs; Are We Frothy?
by Mark Vickery
It's a well-rounded rally, with cyclicals leading the way, demonstrating healthy underpinnings to the overall economy. But is it getting a bit frothy?
5 Must-Watch ETF Charts After Q3 Earnings
by Sweta Killa
Below are five ETFs that buoyed up on strong earnings results.
Treasury Secretary Hands Off to Congress
by Mark Vickery
With things like Pandemic Unemployment Assistance (PUA) and its more than 10 million Americans drawing from it, what happens on January 1st?
ESG ETFs Stand Tall Amid Pandemic: Will They Fail Post Crisis?
by Sanghamitra Saha
Greater exposure to the high-flying tech stocks have made ESG ETFs a winner this year.
Should Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for GSEW
Weekly Jobless Claims Rise to 742K; Macy's (M) Reports Q3 Loss
by Mark Vickery
Initial Jobless Claims went up last week for the first time in a month, from an upwardly revised 711K the previous week to 742K.
Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FTCS
Tesla ETFs Soar on S&P 500 Inclusion News
by Neena Mishra
Here is what investors need to know about Tesla's inclusion in the popular index and related ETFs
Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FLQL
ETF Strategies to Gain From US Market Optimism
by Sweta Jaiswal, FRM
Let's look at some ETF strategies to help investors gain from the optimism surrounding the coronavirus vaccine development as the outbreak continues to aggravate.
Last Week Saw Record Weekly Inflow: Top & Flop ETFs
by Sanghamitra Saha
News that a Pfizer and BioNTech vaccine candidate was more than 90% effective in avoiding COVID-19 news infused $44.5 billion into the stock market last week -- its biggest weekly inflow ever, per BofA, as quoted on MarketWatch.
Vaccine Hopes Push Markets To Frothy Levels: Stocks To Watch
by Daniel Laboe
There is now a more defined light at the end of this pandemic tunnel. Still, we are not out of the woods yet.
Jobless Claims, CPI Down Lower than Expected: 709K, 0.0%
by Mark Vickery
While Initial and Continuing Claims continue their encouraging downward slope, CPI numbers were disappointingly flat.
Should Invesco Russell 1000 Equal Weight ETF (EQAL) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for EQAL
ETFs Riding the Latest Coronavirus Vaccine Optimism Wave
by Sweta Jaiswal, FRM
The coronavirus vaccine progress has brought back optimism for some ETFs, which were largely affected by the outbreak-led slowdown in economic activities.
The Sea Looks Calm: Global Week Ahead
by John Blank
This is not going to be an interesting week, relative to last week's exhausting line-up of major events. ??????That's OK with me. I expect it is OK with you, too.